Cardio Diagnostics Holdings Inc. Warrant financials
$0.01000.00%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.4K | $2.7K | $3.6K | $2.9K | $7.5K | $940.00 | $4.5K | $6.6K | $7.9K | $15.9K | $5.3K | $10.0K |
| Gross profit | $5.4K | $2.7K | $3.6K | $2.9K | $7.5K | $940.00 | $4.5K | $6.6K | $7.9K | $15.9K | $5.3K | $10.0K |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | -$1.5M | -$1.8M | -$1.5M | -$1.7M | -$1.7M | -$1.6M | -$1.5M | -$1.4M | -$1.3M | -$4.2M | -$1.5M | -$1.4M |
| Net income | -$1.5M | -$1.8M | -$1.5M | -$1.7M | -$1.7M | -$1.6M | -$1.5M | -$1.4M | -$1.3M | -$4.2M | -$1.4M | -$1.9M |
| Net margin | −28012.5% | −66722.3% | −41219.9% | −60053.8% | −22517.7% | −173943.0% | −33672.6% | −21467.6% | −16365.9% | −26140.0% | −26156.9% | −19266.0% |
| Diluted EPS | $-0.51 | $-0.63 | $-0.80 | $-0.98 | $-0.97 | $-0.97 | $-1.16 | $-1.73 | $-1.71 | $-5.93 | $-2.19 | $-4.80 |
| EBITDA | -$1.4M | -$1.7M | -$1.4M | -$1.6M | -$1.6M | -$1.5M | -$1.4M | -$1.3M | -$1.2M | -$4.1M | -$1.5M | -$1.4M |
| Operating cash flow | -$1.3M | -$1.6M | -$1.4M | -$1.4M | -$1.6M | -$1.4M | -$1.4M | -$1.2M | -$1.2M | -$1.2M | -$1.7M | -$1.0M |
| Free cash flow | -$1.3M | -$1.6M | -$1.4M | -$1.6M | -$1.6M | -$1.4M | -$1.4M | -$1.2M | -$1.4M | -$1.3M | -$2.2M | -$1.1M |
| Diluted shares | 3.0M | 2.8M | 1.8M | 1.8M | 1.7M | 1.7M | 1.3M | 0.8M | 0.8M | 0.7M | 0.6M | 0.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.6M | $7.1M | $5.1M | $6.4M | $8.0M | $9.7M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $7.9M | $9.6M | $7.8M | $8.8M | $10.4M | $12.3M |
| Total liabilities | $499.8K | $656.0K | $793.1K | $637.3K | $671.8K | $905.0K |
| Shareholders' equity | $7.4M | $8.9M | $7.0M | $8.2M | $9.7M | $11.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology